County
Chaves County EMS
The current listed document is more than 24 months old and may be outdated.
Drugs and doses37
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Gluconate7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 10–15 mg/kg | PO | not captured | standing | page 99 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 11, 101 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 11, 101 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | page 102 |
| Asthma / bronchospasm | peds | 1.25–2.5 mg | NEB | not captured | standing | page 102 |
| Hyperkalemia | adult | 2.5–5 mg | NEB | not captured | standing | pages 20, 102 |
| Hyperkalemia | peds | 1.25–2.5 mg | NEB | not captured | standing | pages 20, 102 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 12, 103 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 12, 103 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 16, 103 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 16, 103 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 17, 100 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | pages 9, 104 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 9, 104 |
| Other | adult | 2 mg | IV | not captured | standing | page 104 |
| Other | adult | 2 mg | IV | not captured | standing | page 104 |
| Other | peds | 0.05 mg/kg | IV | not captured | standing | page 104 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mL | IV | not captured | standing | page 106 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mL/kg | IV | not captured | standing | page 106 |
| Hyperkalemia | adult | 5–10 mL | IV | not captured | standing | pages 20, 106 |
| Hyperkalemia | peds | 0.5 mL/kg | IV | not captured | standing | pages 20, 106 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 106 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 106 |
| Other | peds | 0.5 mL/kg | IV | not captured | standing | page 106 |
| Other | peds | 0.5 mL/kg | IV | not captured | standing | page 106 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Enalapril, Epinephrine, Fentanyl, Furosemide9
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 12.5–50 g | IV | not captured | standing | page 107 |
| Cardiac arrest | peds | 0.5–1 g/kg | IV | not captured | standing | page 107 |
| Hypoglycemia | adult | 12.5–50 g | IV | not captured | standing | pages 14, 107 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | pages 14, 107 |
| Other | adult | 12.5–50 g | IV | not captured | standing | pages 14, 107 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | pages 14, 107 |
| Status epilepticus | adult | 12.5–50 g | IV | not captured | standing | page 107 |
| Status epilepticus | peds | 0.5–1 g/kg | IV | not captured | standing | page 107 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 108 |
| Other | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 108 |
| Other | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 108 |
| Other | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 108 |
| Other | peds | 1 mg | IV/IO | not captured | standing | page 108 |
| Procedural sedation | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 108 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | pages 11, 105, 109 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO | not captured | standing | page 13 |
| Anaphylaxis | adult | 25 mg | IV/IM | not captured | standing | page 13 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV | not captured | standing | page 111 |
| Bradycardia | peds | 5–15 mcg/kg | IV | not captured | standing | page 111 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 111 |
| Cardiogenic shock | peds | 5–15 mcg/kg | IV | not captured | standing | page 111 |
| Other | adult | 5–20 mcg/kg | IV | not captured | standing | page 111 |
| Other | peds | 5–15 mcg/kg | IV | not captured | standing | page 111 |
Enalapril
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 1.25 mg | IV | not captured | standing | page 112 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1–0.5 mg | IV/IO | not captured | standing | pages 13, 114 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 13, 113, 114 |
| Anaphylaxis | adult | 0.3–0.5 mg | SQ | not captured | standing | page 114 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 13, 113, 114 |
| Anaphylaxis | peds | 0.01 mg/kg | SQ | not captured | standing | page 114 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 114 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 16, 113, 114 |
| Cardiac arrest | adult | 2–2.5 mg | ET | not captured | standing | page 114 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 16, 113, 114 |
| Hypotension / shock | adult | 10–20 mcg | IV | not captured | standing | page 114 |
| Hypotension / shock | peds | 0.2 mcg/kg | IV | not captured | standing | page 114 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM | not captured | standing | pages 27, 115 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | pages 27, 115 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO/IM | not captured | standing | pages 30, 115 |
| Procedural sedation | adult | 25–100 mcg | IV/IO/IM | not captured | standing | pages 27, 115 |
| Procedural sedation | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | pages 27, 115 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–40 mg | IV | not captured | standing | page 116 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 116 |
G–L Glucagon, Hydromorphone, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg | IV | not captured | standing | page 117 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–10 mg | IV | not captured | standing | page 117 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 117 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 19, 117 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 19, 117 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5–2 mg | IV/IO/IM | not captured | standing | page 118 |
| Severe pain | peds | 0.01 mg/kg | IV/IO/IM | not captured | standing | page 118 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 250–500 mcg | NEB | not captured | standing | pages 31, 119 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 27, 121 |
| Severe pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 27, 121 |
| Post-intubation sedation | adult | 20 mL/kg | IV | not captured | standing | page 30 |
| Procedural sedation | adult | 2 mg/kg | IV | not captured | standing | page 121 |
| Procedural sedation | peds | 2 mg/kg | IV | not captured | standing | page 121 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 10–30 mg | IV/IM | not captured | standing | page 120 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IO | not captured | standing | page 122 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 123 |
| Other | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 123 |
| Other | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 123 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 123 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 123 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 123 |
| Procedural sedation | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 123 |
| Procedural sedation | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 123 |
| Status epilepticus | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 123 |
| Status epilepticus | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 123 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oxytocin9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1–2 g | IV | not captured | standing | pages 31, 124 |
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV | not captured | standing | pages 33, 124 |
| Other | adult | 2 g | IV | not captured | standing | page 124 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 124 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV | not captured | standing | pages 13, 31 |
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 13 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 31, 125 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | pages 31, 125 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 1 mg | IV | not captured | standing | page 30 |
| Procedural sedation | adult | 1–5 mg | IV/IO/IN | not captured | standing | page 126 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | page 126 |
| Status epilepticus | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | page 126 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 127 |
| ACS / chest pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 127 |
| Other | adult | 2–20 mg | IV/IO/IM | not captured | standing | page 127 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 127 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | IV/IM | not captured | standing | pages 14, 128 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 14, 128 |
| Respiratory distress | adult | 0.4 mg | IV/IM | not captured | standing | pages 14, 128 |
| Respiratory distress | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 14, 128 |
| Seizure | adult | 0.4 mg | IV/IM | not captured | standing | page 128 |
| Seizure | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 128 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 17, 130, 131 |
| CHF / pulmonary edema | adult | 1–3 spray | SL | not captured | standing | page 131 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–30 mcg | IV/IO | not captured | standing | page 129 |
| Other | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 129 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV | not captured | standing | pages 7, 17, 22 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10–20 unit | IV | not captured | standing | pages 23, 134 |
P–R Phenylephrine, Promethazine2
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.5–1 mcg/kg | IV/IO | not captured | standing | page 135 |
| Hypotension / shock | peds | 0.5–1 mcg/kg | IV/IO | not captured | standing | page 135 |
| Other | adult | 0.5–1 mcg/kg | IV/IO | not captured | standing | page 135 |
| Other | adult | 0.5–1 mcg/kg | IV/IO | not captured | standing | page 135 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | pages 7, 22, 136 |
| Nausea / vomiting | adult | 6.25 mg | IV | not captured | standing | pages 22, 136 |
| Nausea / vomiting | peds | 0.25 mg/kg | IM | not captured | standing | pages 7, 22, 136 |
S–Z Sodium Bicarbonate, Thiamine, Vasopressin3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV | not captured | standing | pages 16, 137 |
| Cardiac arrest | peds | 1 mEq/kg | IV | not captured | standing | pages 16, 137 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | pages 18, 137 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 137 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 137 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Alcohol withdrawal | adult | 100 mg | IV/IM | not captured | standing | page 138 |
| Alcohol withdrawal | peds | 10–25 mg | IV/IM | not captured | standing | page 138 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 138 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 138 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 138 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 138 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 138 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 138 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO/ET | not captured | standing | page 139 |
| Sepsis | adult | 0.01–0.04 unit | IV/IO | not captured | standing | page 139 |
Cite this
Chaves County EMS, United States EMS Protocol Census. 142 dose entries, effective 2022-01-01.
https://protoquiz.com/census/agencies/chaves-county-ems/
The census is free and not for sale. Only public agencies are named.